accountSeparately, William Smithburg has stepped down from the board of Northern Trust. Smithburg sits on the board of Abbott...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ABBOTT LABORATORIES
Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.
Abbott Laboratories is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
921 news
and
191 blog
items.
Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from
like-minded professionals.
News
Please add new articles to this topic
Abbott Laboratories reported stronger-than-expected quarterly sales, helped by growth of its Humira arthritis drug and...
commentary are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney, and Abbott...
EARNINGS BEAT: Drug and medical device maker Abbott Laboratories reported better-than-expected earnings Wednesday led...
Drug and medical device maker Abbott Laboratories reported positive first-quarter results Wednesday that edged past...
Tuesday, J&J reported better-than-expected first-quarter earnings and lifted its 2011 financial forecast.
Abbott Laboratories reported a 14% decline in first-quarter earnings on costs associated with acquisitions and employee...
Abbott researchers using a robot to test compounds. (Lane Christiansen/Tribune) Abbott Laboratories��� first-quarter...
Remicade, increased 8.3 percent to $1.29 billion, despite competition from rival biotech drugs like Humira from Abbott...
By , MarketWatch BOSTON (MarketWatch) �� Abbott Laboratories reported a lower first-quarter profit early Wednesday due...
expected (Adds detail on sales, emerging market focus, byline) By Ransdell Pierson NEW YORK, April 20 (Reuters) -...
out yesterday shows generic Vicodin is the most commonly prescribed drug in the U.S. ) More Pharma Earnings: Abbott...
NYSE:IBM) Shares of EMC Corp. (NYSE:EMC) Diversified manufacturers Eaton Corp. (NYSE:ETN) AT&T Inc.
their lowest level in nearly nine years, indications that the market remains depressed. Earnings: Loads of ���em ���...
recent U.S. sales-force cuts, the loss of a key delivery catheter and regulatory tangles. Rising competition from...
treatment Remicade, grew 8.3 percent to $1.29 billion, despite competition from rival biotech drugs such as Abbott...
Stock quotes in this article:ABT More on Press Releases Market Activity Abbott Laboratories| ABT ABBOTT PARK, Ill.
Association of Realtors reports on existing home sales in March. Economists expect five million sales, annualized.
NATICK, Mass. (TheStreet) -- Boston Scientific(BSX) is expected to post a 75% year-over-year decline in adjusted...
already have a presence in the triglyceride or cholesterol-lowering markets. The current major players in those markets...
Indicators: EU-17 Markit Manufacturing PMI (Apr) and Trade Balance (Feb); US Housing Starts (Mar) Wednesday, April 20th...
improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott...
" J&J's Cypher, the first drug-coated stent to reach the U.S. market, has been eclipsed by Abbott Laboratories...
" J&J's Cypher, the first drug-coated stent to reach the U.S. market, has been eclipsed by Abbott Laboratories...
(Adds price increase in third paragraph.) April 15 (Bloomberg) -- Abbott Laboratories agreed to pay $52 million to...
Top Sources: Abbott Laboratories
- BusinessWeek
- MarketWatch
- Reuters
- Chicago Tribune
- thedeal.com
- chicagobusiness.com
- CNN Money
- TheStreet.com
- CNBC
- innovationexcellence.com
